These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35059121)

  • 21. Advanced methodologies for cocrystal synthesis.
    Douroumis D; Ross SA; Nokhodchi A
    Adv Drug Deliv Rev; 2017 Aug; 117():178-195. PubMed ID: 28712924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obtaining Cocrystals by Reaction Crystallization Method: Pharmaceutical Applications.
    Biscaia IFB; Gomes SN; Bernardi LS; Oliveira PR
    Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34204318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenges in Translational Development of Pharmaceutical Cocrystals.
    Kale DP; Zode SS; Bansal AK
    J Pharm Sci; 2017 Feb; 106(2):457-470. PubMed ID: 27914793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent Advances on the Biological Study of Pharmaceutical Cocrystals.
    Wang Z; Xie Y; Yu M; Yang S; Lu Y; Du G
    AAPS PharmSciTech; 2022 Nov; 23(8):303. PubMed ID: 36396736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of Cocrystallization Approach in Drug Development: Recent Patents Review.
    Shah K; Parmar VK
    Recent Pat Nanotechnol; 2018; 12(2):143-154. PubMed ID: 29473529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical cocrystallization techniques. Advances and challenges.
    Rodrigues M; Baptista B; Lopes JA; Sarraguça MC
    Int J Pharm; 2018 Aug; 547(1-2):404-420. PubMed ID: 29890258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs.
    Karagianni A; Malamatari M; Kachrimanis K
    Pharmaceutics; 2018 Jan; 10(1):. PubMed ID: 29370068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous formation and micronization of pharmaceutical cocrystals by rapid expansion of supercritical solutions (RESS).
    Müllers KC; Paisana M; Wahl MA
    Pharm Res; 2015 Feb; 32(2):702-13. PubMed ID: 25213775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Aceclofenac Cocrystals with l-Cystine: Virtual Coformer Screening, Mechanochemical Synthesis, and Physicochemical Investigations.
    Kumar S; Gupta A; Prasad R; Singh S
    Curr Drug Deliv; 2021; 18(1):88-100. PubMed ID: 32807053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicomponent Pharmaceutical Cocrystals: A Novel Approach for Combination Therapy.
    Srivastava D; Fatima Z; Kaur CD
    Mini Rev Med Chem; 2018; 18(14):1160-1167. PubMed ID: 29512461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterizations and Assays of α-Glucosidase Inhibition Activity on Gallic Acid Cocrystals: Can the Cocrystals be Defined as a New Chemical Entity During Binding with the α-Glucosidase?
    Xue N; Jia Y; Li C; He B; Yang C; Wang J
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32150882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges and opportunities of pharmaceutical cocrystals: a focused review on non-steroidal anti-inflammatory drugs.
    Garg U; Azim Y
    RSC Med Chem; 2021 May; 12(5):705-721. PubMed ID: 34124670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.
    Ober CA; Gupta RB
    AAPS PharmSciTech; 2012 Dec; 13(4):1396-406. PubMed ID: 23054991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-Crystals.
    Kumar A; Kumar S; Nanda A
    Adv Pharm Bull; 2018 Aug; 8(3):355-363. PubMed ID: 30276131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal engineering to improve physicochemical properties of mefloquine hydrochloride.
    Yadav AV; Dabke AP; Shete AS
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1036-45. PubMed ID: 20334542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Aceclofenac-l-Cystine and Aceclofenac-Urea Cocrystals with Enhanced Oral Bioavailability.
    Kumar S; Gupta A; Mishra CK; Singh S
    Curr Drug Deliv; 2021; 18(8):1174-1181. PubMed ID: 33602085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Vitro-In Vivo Correlation in Cocrystal Dissolution: Consideration of Drug Release Profiles Based on Coformer Dissolution and Absorption Behavior.
    Kataoka M; Minami K; Takagi T; Amidon GE; Yamashita S
    Mol Pharm; 2021 Nov; 18(11):4122-4130. PubMed ID: 34618448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superior Solubility and Dissolution of Zaltoprofen via Pharmaceutical Cocrystals.
    Panzade P; Shendarkar G
    Turk J Pharm Sci; 2019 Sep; 16(3):310-316. PubMed ID: 32454729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supramolecular Synthon Promiscuity in Phosphoric Acid-Dihydrogen Phosphate Ionic Cocrystals.
    Haskins MM; Lusi M; Zaworotko MJ
    Cryst Growth Des; 2022 May; 22(5):3333-3342. PubMed ID: 35529065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceutical cocrystals: along the path to improved medicines.
    Duggirala NK; Perry ML; Almarsson Ö; Zaworotko MJ
    Chem Commun (Camb); 2016 Jan; 52(4):640-55. PubMed ID: 26565650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.